Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M2TO
|
|||
| Drug Name |
AC1LE05K
|
|||
| Synonyms |
2-cyclohexyl-N-(4H-1,2,4-triazol-3-yl)acetamide; MLS-0072999.0001; 2-cyclohexyl-N-(1H-1,2,4-triazol-5-yl)acetamide; 2-Cyclohexyl-N-(4H-[1,2,4]triazol-3-yl)-acetamide; AC1LE05K; Cambridge id 6726786; MLS000527850; cid_704227; SCHEMBL13934556; CHEMBL1408713; BDBM51399; HMS3315G01; HMS2154C10; ZINC5731798; STK222766; AKOS000643541; MCULE-3724123277; SMR000120424; BAS 04087149; EU-0013407; MLS-0072999.0002; 2-cyclohexyl-N-(1H-1,2,4-triazol-5-yl)ethanamide; Z57261898; 432007-38-0
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H16N4O
|
|||
| Canonical SMILES |
C1CCC(CC1)CC(=O)NC2=NC=NN2
|
|||
| InChI |
1S/C10H16N4O/c15-9(13-10-11-7-12-14-10)6-8-4-2-1-3-5-8/h7-8H,1-6H2,(H2,11,12,13,14,15)
|
|||
| InChIKey |
WOQYWVDZSFPTSS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Endoplasmic reticulum to nucleus signaling 1 (ERN1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Endoplasmic reticulum to nucleus signaling 1 (ERN1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | IRE-1 inhibitors. US9693992. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.